CLASS II Drug recall · Reported 25 Dec 2013 · FDA Enforcement Report

10%, Travasol (Amino Acid) Injection, Pharmacy recalled

Baxter Healthcare is recalling 10%, Travasol (Amino Acid) Injection, Pharmacy Not for Direct Infusion, Baxter Healthcare, distributed nationwide in the US. The recall was initiated on 12 Nov 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: P302646, Exp 5/31/15
NDC0338-0644
Quantity recalled14,622 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-368-2014
FDA event ID
66820
Recalling firm
Baxter Healthcare, Deerfield, IL
Manufacturer
Baxter Healthcare Corporation
Classification
Class II
Status
Terminated
Recall initiated
12 Nov 2013
FDA classified
17 Dec 2013
Reported
25 Dec 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

12 Nov 2013Recall initiated by company
17 Dec 2013Classified by FDA+35 days
25 Dec 2013Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

10%, Travasol (Amino Acid) Injection, 2000 ml, Pharmacy Bulk Package Not for Direct Infusion, Baxter Healthcare Corporation, Clintec Nutrition Division, Deerfield IL 60015 USA. NDC: 0338-0644-06.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured

Which lots are affected?

Lot: P302646, Exp 5/31/15

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Baxter Healthcare

All 572

Other Leucine recalls

All 10